首页>
外国专利>
therapeutic or prophylactic agent for a chorioretinal degenerative disease, and prophylactic or therapeutic method for a chorioretinal degenerative disease
therapeutic or prophylactic agent for a chorioretinal degenerative disease, and prophylactic or therapeutic method for a chorioretinal degenerative disease
Provided is a novel prophylactic or therapeutic agent for a chorioretinal degenerative disease. The compound of formula (1) or its salt has inhibitory effects on photoreceptor cell death or visual cell death in a mouse model of light damage. Therefore, the compound or its salt is useful as a prophylactic or therapeutic agent for a chorioretinal degenerative disease such as age-related macular degeneration, retinitis pigmentosa. In the formula(1), A is a group (p1), (p2) or (p3); R 1 is H, alkyl, aralkyl or OH or its ester; R 2 is H or alkyl; R 3 is halogen, H, alkyl or OH or its ester; R 4 is halogen, H, OH, alkoxy, amino, alkylamino or cycloalkylamino, R 3 and R 4 may be joined to each other through N to form an unsaturated [1,2,4]oxadiazine ring; R 5 is H, alkyl or cycloalkyl; m is 0 or 1; and n is 0 or 1.
展开▼
机译:提供了用于脉络膜视网膜变性疾病的新型预防剂或治疗剂。在光损伤的小鼠模型中,式(1)的化合物或其盐对光感受器细胞死亡或视觉细胞死亡具有抑制作用。因此,该化合物或其盐可用作脉络膜视网膜变性疾病如年龄相关性黄斑变性,色素性视网膜炎的预防或治疗剂。在式(1)中,A为基团(p1),(p2)或(p3); R 1为H,烷基,芳烷基或OH或其酯; R 2为H或烷基; R 3为卤素,H,烷基或OH或其酯; R 4是卤素,H,OH,烷氧基,氨基,烷基氨基或环烷基氨基,R 3和R 4可以通过N相互连接形成不饱和的[1,2,4]恶二嗪环; R 5为H,烷基或环烷基; m为0或1; n为0或1。
展开▼